It looks like the uptrend trend in Earth Life Sciences Inc (OTCMKTS:CLTS) has already begun. CLTS share prices have more than doubled in the last 5 trading sessions on low volume kicking off all the indicators of a potential rally. CLTS recently acquired 100% of assets of Gold Buck and White Channel, both located in British Columbia, Canada. The acquisitions add to Earth’s portfolio of projects, but what exactly is the company getting from the deals ? From White Channel, Earth Life Sciences Inc (OTCMKTS:CLTS) is getting primarily silica-gold assets, with the management targeting to embark on scale production later this year. The purchase of White Channel assets expands Earth’s portfolio of high-quality assets.

From Gold Buck, CLTS is getting its hands on mainly copper assets, but there are also silver and gold. CLTS sees huge monetization opportunity in the Gold Buck project. Overall, acquisition of Gold Buck and White Channel projects bring to Earth Life Sciences Inc (OTCMKTS:CLTS) high value and promising assets that have the potential to appreciate in the coming years.

Newport Corp (NASDAQ:NEWP) in an $897 million buyout deal

Newport Corp (NASDAQ:NEWP) has accepted to be acquired by MKS Instruments, Inc. (NASDAQ:MKSI) for $897 million in cash. The news of the deal was received positively on the market, sending Newport’s shares up more than 51%.

The $897 million buyout price values Newport Corp (NASDAQ:NEWP) at $23 per share. That reflects a 53% premium over the price immediately before the deal was made public.Newport and MKS Instruments hope to close the deal in 2Q2015. On its part, MKS Instruments expects the acquisition of Newport to be accretive to earnings in the first one year and also shed $35 million in annual costs within three years after closing the transaction.

Newport Corp (NASDAQ:NEWP) stands to walk away with $32.6 million in case the deal fails to close.

Point.360 (OTCMKTS:PTSX)’s sales increase sharply

Point.360 (OTCMKTS:PTSX) reported a sharp increase in sales for the last three months of 2015. Sales of $9.7 million for the quarter compared with $5.4 million in a similar period a year earlier. However, Point.360 (OTCMKTS:PTSX)’s EPS loss of $0.18 was larger than $0.10 in the year-ago quarter.

Second Sight Medical Products Inc (NASDAQ:EYES) on five-year clinical data release

Second Sight Medical Products Inc(NASDAQ:EYES) will for the first time present data covering five years on the outcome related to Argus II, which is a vision correction system. Second Sight Medical Products Inc (NASDAQ:EYES) will release the data at an event at Eden Roc Miami Beach between Feb. 24 and Feb. 27.

China Zenix Auto International Ltd (NYSE:ZX) goes against the grain

When Asian ADRs were tumbling, China Zenix Auto International Ltd (NYSE:ZX) took a different course, rising nearly 27%. Hope of strengthening automotive industry and other factors helped China Zenix Auto defy the gravity that was pulling down many Asian ADRs.